Feedback / Questions
RGLS4326 - Regulus Therapeutics
https://www.prnewswire.com/news-releases/regulus-therapeutics-reinitiates-multiple-ascending-dose-study-of-rgls4326-for-the-treatment-of-adpkd-301004911.html
Feb 13, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next